Rui Fujimura

Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia <i>via</i> indoxyl sulfate‐induced mitochondrial dysfunction

Yuki Enoki, Hiroshi Watanabe, Riho Arake et al. · Journal of Cachexia Sarcopenia and Muscle · 2017 · 153 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis

Jing Bi, Hiroshi Watanabe, Rui Fujimura et al. · Scientific Reports · 2018 · 30 citations · Full text

Medicine, Biochemistry, Pathobiology +17

Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism

Hiroshi Watanabe, Ryusei Sugimoto, Komei Ikegami et al. · Biochemical Pharmacology · 2017 · 27 citations

Medicine, Endocrinology, Pharmacology +14

Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice

Kento Nishida, Hiroshi Watanabe, Masako Miyahisa et al. · Scientific Reports · 2020 · 20 citations · Full text

Medicine, Immunology, Pharmacology +17

An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action

Hiroshi Watanabe, Rui Fujimura, Yuto Hiramoto et al. · Scientific Reports · 2021 · 18 citations · Full text

Medicine, Nephrology, Pathobiology +17